Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:269-270 (5 August), doi:10.1136/bmj.333.7562.269
MRSA policies divert attention from MSSA and may risk lives
| The first 150 words of the full text of this article appear below. |
In the United Kingdom reporting of bacteraemia due to methicillin resistant Staphylococcus aureus (MRSA) infections is mandatory, and reduction in bacteraemia rates is a performance target for NHS trusts. Rates of S aureus bacteraemia remain high around the world, so we need forms of surveillance that will allow better understanding of its causes.
In this week's BMJ Wyllie and colleagues describe the use of linked data in Oxfordshire hospitals to investigate secular trends in bacteraemia caused by S aureus.1 Using anonymised data on hospital admissions of patients and linking them to information on isolates of S aureus, Wyllie and colleagues found that about a third of patients with S aureus bacteraemia died within 30 days. The risk of death was similar for methicillin sensitive and methicillin resistant S aureus infections.
Between 1997 and 2003, rates of MRSA in these Oxfordshire hospitals increased while rates for methicillin sensitive
John Paul, consultant
Microbiology Department, Royal Sussex County Hospital, Brighton BN2 5BE
(tetrix@pavilion.co.uk)
Read all Rapid Responses